Bellerophon Therapeutics Inc buy melinda
Start price
21.02.17
/
50%
€15.83
Target price
27.02.17
€27.06
Performance (%)
12.82%
End price
27.02.17
€17.86
Summary
This prediction ended on 27.02.17 with a price of €17.86. The prediction had a final performance of 12.82%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bellerophon Therapeutics Inc | - | - | - | - |
iShares Core DAX® | 1.743% | 1.903% | 18.038% | 16.248% |
iShares Nasdaq 100 | -2.088% | -0.640% | 25.594% | 34.551% |
iShares Nikkei 225® | 1.306% | 4.161% | 16.556% | 10.486% |
iShares S&P 500 | -0.093% | 0.169% | 24.312% | 36.773% |
Comments by melinda for this prediction
In the thread Bellerophon Therapeutics Inc diskutieren
31/03/2017 initiiert Phase 2. Mai 2016. Daten für 1Q 2017
pulmonaler Hypertonie
(Vom Mitglied beendet)
Stopped prediction by melinda for Bellerophon Therapeutics Inc
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€8.66
25.05.19
25.05.19
€16.24
04.11.21
04.11.21
-96.60%
04.01.21
04.01.21
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€36.53
16.12.17
16.12.17
€40.59
18.06.18
18.06.18
-9.26%
18.06.18
18.06.18
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€40.50
16.12.17
16.12.17
€45.00
18.06.18
18.06.18
-9.26%
18.06.18
18.06.18
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€25.91
08.03.17
08.03.17
€33.83
08.09.17
08.09.17
-39.41%
08.09.17
08.09.17
Bellerophon Therapeutics Inc
Start price
Target price
Perf. (%)
€9.76
12.02.17
12.02.17
€10.82
14.02.17
14.02.17
28.93%
14.02.17
14.02.17